Cognitive deterioration in patients with early multiple sclerosis: a 5-year study
- PMID: 21746743
- DOI: 10.1136/jnnp.2010.237834
Cognitive deterioration in patients with early multiple sclerosis: a 5-year study
Abstract
Objective: The objective was to investigate changes in cognitive functioning in subjects with early multiple sclerosis (MS) over 5 years. Methodological issues associated with longitudinal cognitive research such as practice effects and drop-outs were also examined.
Methods: Ninety subjects with a diagnosis of clinically isolated syndrome or MS and disease duration from a first symptom of ≤ 6 years participated in the study. Subjects were administered the Brief Repeatable Battery of Neuropsychological Tests in MS, which includes five measures assessing four cognitive domains. As a means of stabilising practice effects, the battery was administered 1-2 weeks apart at enrollment and then annually for up to 5 years.
Results: Significant deterioration was found on a measure of working memory and speed of information processing. Significant deterioration was also found on measures of immediate and delayed visual spatial memory. Verbal memory was unchanged over the course of the study. Improved performance was observed on a second measure of speed of information processing and on a measure of verbal fluency. Among subjects with longitudinal follow-up, the drop-out rate was 30%, but subjects who dropped out did not differ from those who completed the study in terms of baseline cognitive performance or the change in cognitive performance from year 1 to year 2.
Conclusions: Subjects with early MS showed a deterioration in working memory and visual spatial memory over a period of up to 5 years. Although significant practice effects were associated with several cognitive measures, the Symbol Digit Modality Test may be useful for longitudinal evaluations of cognitive functioning in MS.
Similar articles
-
[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. Encephale. 2008. PMID: 19081451 French.
-
Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.Eur Neurol. 2007;57(4):193-202. doi: 10.1159/000099158. Epub 2007 Jan 1. Eur Neurol. 2007. PMID: 17272938
-
Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):878-85. doi: 10.1136/jnnp.74.7.878. J Neurol Neurosurg Psychiatry. 2003. PMID: 12810771 Free PMC article.
-
Cognitive assessment in patients with multiple sclerosis: From neuropsychological batteries to ecological tools.Ann Phys Rehabil Med. 2020 Mar;63(2):154-158. doi: 10.1016/j.rehab.2018.01.006. Epub 2018 Feb 17. Ann Phys Rehabil Med. 2020. PMID: 29462665 Review.
-
The relationship between depression and cognitive performance in multiple sclerosis: A meta-analysis.Clin Neuropsychol. 2024 Jan;38(1):21-41. doi: 10.1080/13854046.2023.2192963. Epub 2023 Mar 25. Clin Neuropsychol. 2024. PMID: 36964744 Review.
Cited by
-
Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.J Neurol. 2014 Sep;261(9):1735-44. doi: 10.1007/s00415-014-7413-9. Epub 2014 Jun 22. J Neurol. 2014. PMID: 24952618
-
Cognitive Dysfunction in Multiple Sclerosis: Educational Level as a Protective Factor.Neurol Int. 2021 Jul 22;13(3):335-342. doi: 10.3390/neurolint13030034. Neurol Int. 2021. PMID: 34449709 Free PMC article.
-
Limited health literacy and decline in executive function in older adults.J Health Commun. 2013;18 Suppl 1(Suppl 1):143-57. doi: 10.1080/10810730.2013.825673. J Health Commun. 2013. PMID: 24093352 Free PMC article. Clinical Trial.
-
Longitudinal Trajectories of Digital Cognitive Biomarkers for Multiple Sclerosis.Ann Clin Transl Neurol. 2025 Apr;12(4):842-850. doi: 10.1002/acn3.70015. Epub 2025 Feb 25. Ann Clin Transl Neurol. 2025. PMID: 40007145 Free PMC article.
-
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.Front Neurol. 2015 May 11;6:97. doi: 10.3389/fneur.2015.00097. eCollection 2015. Front Neurol. 2015. PMID: 26029156 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials